Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis.
Cover picture: eur. J. Immunol. 5'15.
Patterns of Objective and Subjective Burden of Informal Caregivers in Multiple Sclerosis.
Rhabdomyolysis following interferon-beta treatment in a patient with multiple sclerosis - A case report.
Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy.
Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.
Vaccines in Multiple Sclerosis.
Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.
High nationwide incidence of multiple sclerosis in sweden.
A Limited Form of Neuromyelitis Optica With a Lesion of the Fourth Nerve Nucleus.
Fingolimod and cardiac risk: latest findings and clinical implications.
Possible Relations Between Epstein-Barr Virus Past Infection and Classic Multiple Sclerosis in Guilan, Iran.
The antiviral drug ganciclovir does not inhibit microglial proliferation and activation.
Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
The effect of B-cell depletion in the Theiler's model of multiple sclerosis.
Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases.
A rare case of nonenhancing primary central nervous system lymphoma mimic multiple sclerosis.
Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk.
Tysabri® (natalizumab) data at ECTRIMS reaffirm positive effects of treatment for people with relapsing forms of MS
Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited.
A white matter lesion-filling approach to improve brain tissue volume measurements.
Normal Diffusion-Weighted MRI During the Acute Stage of Central Pontine Myelinolysis.
Primary progressive multiple sclerosis developing in the context of young onset Parkinson's disease.
Fumaric Acid Esters Stimulate Astrocytic VEGF Expression through HIF-1α and Nrf2.
Pages
« first
‹ previous
…
708
709
710
711
712
713
714
715
716
…
next ›
last »